Assess an author's data and outputs

Author Review — Chang Liu

What the supplied metrics tell us

• Small primary output: three listed works is a limited corpus for assessing research influence; raw counts say little about quality, novelty, or field impact without venue, citations, or years.
• Zero citations / h-index 0: indicates the works (as indexed/queried) have not been cited by other indexed literature yet — this can reflect low visibility, non-indexed venues, recent publication, or mismatch of name disambiguation (many researchers share similar names).

Critical appraisal (evidence-based & skeptical)

Key interpretive points — each claim below is conservative and cites general bibliometric guidance.

1. h-index and citation counts are context-dependent: a single low h-index is common for early-career authors or for publications in non-indexed/local-language outlets; the h-index alone cannot determine competence or the scientific strength of methods reported in the papers (Hirsch on the h-index).
2. Name disambiguation risk: 'Chang Liu' is a common East-Asian name; bibliometric services can conflate or split records (false positives/negatives). Open metadata matching (ORCID, institutional affiliation, email) is necessary to ascribe outputs correctly — absence of affiliation strongly increases misattribution risk (recommend verifying ORCID/author IDs with primary sources).
3. Venue and peer-review matter: raw counts don't show whether papers were peer-reviewed, conference abstracts, theses, or local reports; the scientific strength of an author should be judged by methods, data transparency, reproducibility, and peer review — not raw counts alone. For proper assessment, fetch full-texts, methods sections, sample sizes, and data/code availability statements.
4. Possible language/discipline boundary: the three titles are in Korean; non-English local-language scholarship is often under-indexed by global citation indices — low citation counts may therefore underestimate real-world impact within a local clinical/technical community.

Immediate blindspots & what would change the conclusion

• Missing authoritative identifiers: ORCID, institutional homepage, Scopus/OpenAlex/ResearcherID links for this specific 'Chang Liu' (the OpenAlex search for 'Chang Liu' often returns many different persons; disambiguation is essential).
• Missing journal/venue metadata and publication dates — knowing these would permit assessment of peer-review quality and field-level citation expectations.
• Access to full texts and methods to judge scientific rigor (sample sizes, controls, statistics, data/code sharing) — without these we cannot evaluate experimental quality.

Concrete, evidence-focused recommendations

1. Provide disambiguating identifiers (ORCID, email, institutional page) so we can fetch authoritative bibliographic records and full texts.
2. Share DOIs or PDF/full-text links for the three listed works so we can evaluate methods, sample sizes, and data availability (this permits paper-level scoring: rigor, novelty, reproducibility).
3. If the works are in non-indexed/local outlets, compile supporting metrics: conference proceedings, local citations, policy/technical impact evidence, and translations.
4. Run an author-level disambiguation check (OpenAlex/Scopus/WoS/Google Scholar/ORCID) and produce a cleaned publication list and citation timeline — I can do this if you provide permission and identifiers.

What I did / data provenance

This review relies on the author metadata you supplied (paper list, paperCount=3, h-index=0, citations=0) and standard bibliometric reasoning (h-index interpretation per Hirsch). I did not infer additional publications or metrics beyond what you provided; the critiques emphasize what cannot be concluded from the supplied data and what evidence would change the assessment (Leiden Manifesto on responsible metrics).

Next-step actions I can run for you (one-click)

Quick decision rules (if you must triage this author)

• Accept 'low-risk' status for non-clinical hobby/essay-style works, but insist on peer-reviewed evidence before treating outputs as scientific claims.
• Flag for deeper review if any of the three papers claim clinical/biological interventions, causal claims, or public-health recommendations — those require reproducible methods and independent validation.
• If you want a fast authoritative assessment, supply ORCID or PDFs and I'll run a reproducibility/rigor checklist and compute field-normalized citation percentiles.